ResearchMoz

2020 Foresight Report: Luxury Investments

Timetric
Published Date » 2013-10-03
No. Of Pages » 78
   
  Synopsis  
   
 
 
 This report examines the attitudes of high net worth individuals (HNWIs) to luxury investments and products and services that have arisen and are expected to evolve to accommodate demands from clients by service providers 
 This report focuses on luxury investments, as opposed to luxury goods or luxury retail 
 The report provides comprehensive analysis on market potentials and key trends and drivers impacting the growth of the luxury investments market 
 The report analyzes key segments of luxury investments (art, wine, classic cars, gems, jewelry and watches) and provides insights into where future growth and opportunities lie 
 
 
   
  Executive summary  
   
 Since 2007, an increasing number of HNWIs have shown interest in alternative...
Table of contents

1 Introduction
1.1 What is this report about?
1.2 Definitions
1.2.1 Art
1.2.2 Classic Cars
1.2.3 Gems, Jewelry and Watches
1.2.4 Wine

2 Executive Summary

3 Global Luxury Investments Current Future and Trends
3.1 Global Market Size and Forecast
3.1.1 Luxury investments in developed countries
3.1.2 Luxury investments in emerging countries
3.2 Share of Luxury Investments in Total Alternative Assets
3.2.1 Share of luxury investments in total alternative assets in developed countries
3.2.2 Share of luxury investments in total alternative assets in emerging countries
3.3 Share of Luxury InvestmentsinTotal Assets
3.3.1 Share of luxury investments in total assets in developed countries
3.3.2 Share of luxury investments in total assets in emerging countries

4 Art
4.1 Analysis of Key Trends and Drivers
4.1.1 Growth of the art market
4.1.2 Asia-Pacific
4.1.3 The Americas
4.1.4 Europe

5 Classic cars
5.1 Analysis of Key Trends and Drivers
5.1.1 Growth of the classic car market
5.1.2 Asia-Pacific
5.1.3 Americas
5.1.4 Europe

6 Gems, Jewelry and Watches
6.1 Analysis of Key Trends and Drivers
6.1.1 Gems
6.1.2 Jewelry
6.1.3 Watches
6.1.4 Asia-Pacific
6.1.5 The Americas
6.1.6 Europe

7 Wines
7.1 Analysis of Key Trends and Drivers
7.1.1 Wine investment funds
7.1.2 Asia-Pacific
7.1.3 The Americas
7.1.4 Europe

8 About WealthInsight

List of Tables


Table 1: Global HNWI Luxury Investments Value (US$ Billion), 2008–2012
Table 2: Global HNWI Luxury Investments Value (US$ Billion), 2013–2017
Table 3: Luxury Investments in Developed Countries Value (US$ Billion), 2008–2017
Table 4: Luxury Investments in Developing Countries Value (US$ Billion), 2008–2017
Table 5: Global HNWI Share of Luxury Investments in Total Alternative Assets, 2008–2017
Table 6: Global HNWI Share of Luxury Investments in Total Alternative Assets, 2008–2017
Table 7: Share of Luxury Investments in Total Alternative Assets in Developed Countries 2008–2017
Table 8: Share of Luxury Investments in Total Alternative Assets in Emerging Countries, 2008–2017
Table 9: Global HNWI Share of Luxury Investments in Total Assets, 2008–2017
Table 10: Share of Luxury Investments in Total Assets in Developed Countries, 2008–2017
Table 11: Share of Luxury Investments in TotalAssets in Emerging Countries, 2008–2017

List of Figures


Figure 1: Global Opportunity in Luxury Investments 
Figure 2: Global HNWI Luxury Investments Value (US$ Billion), 2008–2012 
Figure 3: Global HNWI Luxury Investments Value (US$ Billion), 2013–2017 
Figure 4: Global Trends in “Art, Wine and Wheels”,2008–2012 
Figure 5: Financial planning for art assets within a family office platform 
Figure 6: Analysis of Key Art Market Trends and Drivers 
Figure 7: Comparison of the Performance of the Art Index with Equity Indices, 2008–2012
Figure 8: Comparison of the Performance of Classic Cars with Equity Indices, 2008–2012 
Figure 9: Analysis of Key Classic Car Market Trends and Drivers 
Figure 10: Comparison of the Performance of Gold and Gem Prices with Equity Indices, 2008–2012 
Figure 11: Analysis of Key Gems, Jewelry and Watches Investment Trends and Drivers 
Figure 12: Comparison of the Performance of the Wine Index with Equity Indices, 2008–2012 
Figure 13: Analysis of Key Wine Investment Market Trends and Drivers

Upcoming Reports:

Pulmonary Arterial Hypertension (PAH) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Pulmonary arterial hypertension (PAH), a type of pulmonary hypertension results from high blood pressure associated with arteries of the lungs. In PAH, the arteries of the lungs (pulmonary arteries) become narrower than their actual size, giving rise to high blood pressure in the arteries of the lungs thus putting pressure on the right ventricle of the heart. Some of the main causes of occurrences of this disease are bad habits such as stressful lifestyle, intake of certain medicines etc. There is no exact treatment available for PAH but existing medication may help treat the symptoms....
Greece: fertilizers market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fertilizers market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fertilizers market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Poland: cement clinker market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the cement clinker market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the cement clinker market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...